These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23632982)

  • 1. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke.
    Kamel H; Elkind MS; Bhave PD; Navi BB; Okin PM; Iadecola C; Devereux RB; Fink ME
    Stroke; 2013 Jun; 44(6):1550-4. PubMed ID: 23632982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Paroxysmal Supraventricular Tachycardia with Ischemic Stroke: A National Case-Control Study.
    Chiang JK; Kao HH; Kao YH
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1493-1499. PubMed ID: 28366662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is paroxysmal supraventricular tachycardia truly benign? Insightful association between PSVT and stroke from a National Inpatient Database Study.
    Sharma SP; Kondur A; Gopinathannair R; Kamerzell T; Mansour M; Mahapatra S; Bartus K; Lakkireddy D
    J Interv Card Electrophysiol; 2020 Oct; 59(1):35-41. PubMed ID: 31728874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia.
    Go AS; Hlatky MA; Liu TI; Fan D; Garcia EA; Sung SH; Solomon MD
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia.
    Hamer ME; Wilkinson WE; Clair WK; Page RL; McCarthy EA; Pritchett EL
    J Am Coll Cardiol; 1995 Apr; 25(5):984-8. PubMed ID: 7897142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States.
    Rehorn M; Sacks NC; Emden MR; Healey B; Preib MT; Cyr PL; Pokorney SD
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2199-2206. PubMed ID: 34028109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative atrial fibrillation and the long-term risk of ischemic stroke.
    Gialdini G; Nearing K; Bhave PD; Bonuccelli U; Iadecola C; Healey JS; Kamel H
    JAMA; 2014 Aug; 312(6):616-22. PubMed ID: 25117130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice makes perfect: relationship between hospital procedure volume and permanent pacemaker implantation after paroxysmal supraventricular tachycardia ablation.
    Agarwal V; Shah N; Mehta K; Agarwal A; Willner J; Lafferty J
    J Interv Card Electrophysiol; 2017 Nov; 50(2):141-147. PubMed ID: 29134433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States.
    Chew DS; Sacks NC; Emden MR; Preib MT; Cyr PL; Wood D; Pokorney SD
    Am Heart J; 2021 Mar; 233():132-140. PubMed ID: 33359780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on the occurrence of atrial fibrillation in paroxysmal supraventricular tachycardia.
    Roark SF; McCarthy EA; Lee KL; Pritchett EL
    Am J Cardiol; 1986 Mar; 57(8):571-5. PubMed ID: 3953441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after radiofrequency ablation of paroxysmal supraventricular tachycardia in patients with tachycardia-induced atrial fibrillation.
    Weiss R; Knight BP; Bahu M; Zivin A; Souza J; Goyal R; Daoud E; Man KC; Strickberger SA; Morady F
    Am J Cardiol; 1997 Dec; 80(12):1609-10. PubMed ID: 9416948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
    Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
    Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variation of short-lasting asymptomatic paroxysmal supraventricular tachycardia.
    Watanabe M; Nakagawa M; Nobe S; Ohie T; Takahashi N; Hara M; Yonemochi H; Ito M; Saikawa T
    J Electrocardiol; 2002 Apr; 35(2):135-8. PubMed ID: 11953912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.
    Gausche M; Persse DE; Sugarman T; Shea SR; Palmer GL; Lewis RJ; Brueske PJ; Mahadevan S; Melio FR; Kuwate JH
    Ann Emerg Med; 1994 Aug; 24(2):183-9. PubMed ID: 8037382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal supraventricular tachycardia: outcome after ED care.
    Luber S; Brady WJ; Joyce T; Perron AD
    Am J Emerg Med; 2001 Jan; 19(1):40-2. PubMed ID: 11146016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia due to atrioventricular nodal reentry.
    Hurwitz JL; German LD; Packer DL; Wharton JM; McCarthy EA; Wilkinson WE; Prystowsky EN; Pritchett EL
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):705-10. PubMed ID: 1695348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of inducible paroxysmal supraventricular tachycardia during esophageal electrophysiologic study in patients with unexplained stroke.
    Brembilla-Perrot B; Blangy H
    Int J Cardiol; 2006 May; 109(3):344-50. PubMed ID: 16039731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
    Page RL; Connolly SJ; Wilkinson WE; Marcello SR; Schnell DJ; Pritchett EL;
    Am Heart J; 2002 Apr; 143(4):643-9. PubMed ID: 11923801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.